Tilray Sued By Four20 For $130 Million In Damages

It appears that the cannabis sector is just firing up in terms of lawsuits. Following iAnthus Capital’s announcement this morning that they had filed a lawsuit against a significant lender, BNN Bloomberg broke the story that Tilray Inc (NASDAQ: TLRY) has been sued by that of 420 Investments Ltd, the firm behind the Alberta-based Four20 retailer.

The lawsuit is in relation to the previously announced definitive agreement entered between Tilray and Four20. Under the terms of the arrangement, Tilray had agreed to purchase the Alberta retailer for $110 million in an all-stock transaction. Payment was to consist of an initial $70 million in Class 2 common stock of Tilray as well as earn-outs of up to $40 million in common stock, as per the official company news release.

However, as per BNN Bloomberg’s report this morning, Tilray walked from that deal last week due to “a change of heart.” Four20 subsequently filed a statement of claim for $110 million plus an additional $20 million in damages in Alberta against Tilray as a result. The company has also stated it will not be paying back a $7 million bridge loan provided by Tilray to fund additional store openings.

Four20 filed the claim on the grounds that they don’t believe Tilray had the right to terminate the agreement, which Tilray denies. Tilray as a result intends to defend itself, stating that they are confident they have the right to terminate the agreement, while blaming Four20 for not meeting conditions required to close the arrangement.

Tilray last traded at $14.23 on the Nasdaq.


Information for this briefing was found via Sedar, BNN Bloomberg and Tilray. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

This Gold Story Starts With Cash Flow | Gordon Robb – ESGold

Silverco Cusi Mine PEA: Bigger Isn’t Always Better

Fixing Heart Disease Tied to Sudden Death in Young People | David Elsley – Cardiol Therapeutics

Recommended

Silver47 Eyes Discovery in Nevada After Tripling Kennedy Project Footprint

Total Metals Secures High Grade Critical Minerals Property In Northwestern Ontario

Related News

Tilray Sees Revenue Decline To $144.1 Million In Q2 2023

Tilray Brands (TSX: TLRY) appears to be struggling when it comes to topline revenue. The...

Monday, January 9, 2023, 08:29:13 AM

Tilray Sinks 22% In Pre-Market Trading After Lending Shares To Shorts For Note Offering

Tilray Brands (NASDAQ: TLRY) is currently down nearly 23% in pre-market trading follow the after-hours...

Friday, May 26, 2023, 09:01:57 AM

Tilray Brands Posts Net Loss Of $85 Million In Q2 2025

Tilray Brands (TSX: TLRY) this morning reported its second quarter financial results, posting topline revenue...

Friday, January 10, 2025, 09:07:34 AM

Hexo Announces US$40 Million ATM Financing, Has Less Than Two Months Cash Remaining

Hexo Corp (TSX: HEXO) is looking to dilute its current shareholders once again. The firm...

Tuesday, May 3, 2022, 10:48:32 AM

Tilray Hires New Chief Financial Officer, Chief Operating Officer

Tilray Inc (NASDAQ: TLRY) has bolstered its executive team this morning, with the appointment of...

Tuesday, January 14, 2020, 08:37:56 AM